Oct 21, 2025 10:00 AM Eastern Daylight Time Enpro Announces Date for Third Quarter 2025 Earnings Release and Conference Call Share CHARLOTTE, N.C.--(BUSINESS WIRE)--Enpro Inc. (NYSE: NPO) will release financial results for the third quarter of 2025 on Tuesday, November 4, at 6:30 a.m. Eastern Time. Eric Vaillancourt, President and Chief Executive Officer, and Joe Bruderek, Executive Vice President and Chief Financial Officer, will host a conference call to review the company's performance at 8:30 a.m. Easte ...

Contacts Investor Contacts:James GentileVice President, Investor Relations Jenny YeeCorporate Access Specialist Oct 21, 2025 10:00 AM Eastern Daylight Time Enpro Announces Date for Third Quarter 2025 Earnings Release and Conference Call Share CHARLOTTE, N.C.--(BUSINESS WIRE)--Enpro Inc. (NYSE: NPO) will release financial results for the third quarter of 2025 on Tuesday, November 4, at 6:30 a.m. Eastern Time. Eric Vaillancourt, President and Chief Executive Officer, and Joe Bruderek, Executive Vice President ...

Company Overview - WellTheory, a health technology startup focused on autoimmune care, has secured $14 million in Series A funding led by General Catalyst, with participation from several other investors [1][2] - The company was founded by Ellen Rudolph in 2022, aiming to transform traditional care models for autoimmune diseases through holistic and personalized programs [2] Market Opportunity - The autoimmune disease market is significant, with over 50 million Americans affected by conditions such as rheumatoid arthritis, lupus, and multiple sclerosis, a number that has more than doubled in the last 30 years [3] - The economic burden of autoimmune diseases is projected to reach $180 billion by 2025, with costs expected to double in the next 15 years if new treatments do not emerge [4] Business Model and Services - WellTheory offers personalized care plans for over 100 distinct autoimmune diagnoses, focusing on the root causes of symptoms rather than treating them in isolation [4] - The company utilizes proprietary AI tools, including Care Hub and Care Scribe, to streamline treatment plans and improve operational efficiency [5] Team and Support Structure - Members of WellTheory work with a human care team that includes a registered dietitian, a certified health coach, and a care coordinator, providing one-on-one sessions and unlimited messaging [6] Funding Significance - The recent funding round is notable as all institutional investors involved were female partners, highlighting the rarity of female-led startups receiving venture capital, which accounts for less than 2% of total funding [6]

Core Insights - Humata Health announced plans to integrate its AI-powered prior authorization technology with Microsoft Dragon Copilot, enhancing clinical workflows [1] Company Developments - The integration aims to automate and streamline prior authorization tasks for clinicians, thereby reducing their workload [1] - This technology is expected to accelerate patient access to appropriate care, indicating a focus on improving healthcare efficiency [1]

Core Points - Mirion Technologies, Inc. will release its financial results for the third quarter of 2025 after market close on October 28, 2025, followed by a conference call on October 29, 2025, at 11:00 am ET to discuss the results [1] - Participants can access the conference call by dialing specific numbers or through a live webcast available on the company's investor relations website [2] - A telephonic replay of the call will be available until November 12, 2025, with access provided through designated phone numbers and an access code [3] Company Overview - Mirion is a global leader in radiation safety, science, and medicine, focusing on innovations that provide vital protection while utilizing ionizing radiation across various end markets [4] - The company operates in sectors such as nuclear safety, healthcare, and diagnostic imaging, employing approximately 2,800 people across 12 countries [4]

Oct 15, 2025 9:30 AM Eastern Daylight Time Wolters Kluwer Helps Digital Health Platforms Seamlessly Embed Trusted Clinical Content With New UpToDate Connect Share "This integration marks a significant step forward in bringing trusted, real-time insights directly into the said Jean-Claude Saghbini, chief technology officer and president of Technology clinical moment,†Services at Lumeris. "By combining UpToDate's evidence-based clinical decision support depth with Tom's AI-powered actions, we're not just in ...

Core Insights - The Verily Consumer Survey indicates a strong consumer demand for personalized health recommendations, easier access to health records, and streamlined health technology experiences [1][2][4] Survey Overview - The survey was conducted online in July 2025, involving over 2,000 U.S. adults who own smartphones and make healthcare decisions [3][11] - Respondents expressed a desire for health technology solutions that enhance their engagement and control over health decision-making [3][4] Consumer Preferences - 76% of respondents want an app that helps them understand their health over time, while 75% desire personalized health recommendations from healthcare professionals [6] - 81% believe that easier access to health information would increase their sense of control over their health [6] - 82% wish to access all their health information in one place, with 36% using multiple platforms across different healthcare providers [6][7] Current Technology Usage - 73% of respondents use at least one online patient portal, and 47% use health wearable tracking devices [7] - 60% actively seek new digital health tools, but 59% find it challenging to navigate health records due to lack of consolidation [7][8] Challenges Identified - 64% of users find current health apps frustrating, primarily due to lack of integration and inaccurate information [7] - 62% of online portal users experience issues like forgotten passwords, and 41% feel overwhelmed by the number of portals [7] Health Conditions Impact - 37% of respondents reported having at least one cardiometabolic condition, and those with such conditions are more likely to use multiple online patient portals and express frustration with current health apps [8] Industry Opportunities - The survey highlights a significant opportunity for the health technology industry to provide more integrated, personalized, and trustworthy digital care solutions [4][9]

Core Insights - Counterpart Health has appointed Blaine Lindsey as Vice President of Enterprise Growth and Partnerships and Shannon Jacobs as President of Market Operations for the Gulf Region to enhance partnerships and operational support for the Counterpart Assistant platform [1][4][6] Group 1: Leadership Appointments - Blaine Lindsey will focus on expanding Counterpart Assistant's reach to risk-bearing organizations, leveraging his extensive experience in value-based care and partnership development [4][5] - Shannon Jacobs will lead the growth and optimization of Counterpart's physician network in the Gulf Region, drawing on his operational expertise from his previous role at Main Street Health [6][7] Group 2: Technology and Market Needs - Counterpart Assistant aims to address the technology and operational gaps faced by physicians, particularly in underserved areas, by providing AI-powered insights that enhance patient care and support value-based care [2][3] - The platform has demonstrated effectiveness in managing chronic conditions and improving clinical quality, with studies highlighting its impact on various health issues [8][9] Group 3: Strategic Goals - The company is focused on converting growing demand for Counterpart Assistant into strategic partnerships that yield measurable results for clinicians [5] - The leadership changes are expected to facilitate the scaling of operations and enhance the delivery of high-quality care across diverse practice environments [6][7]

MCLEAN, Va., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for its clients and the populations they serve, today announced that its Chief People Officer, Kelly Schlageter, has been named a 2025 Women in Leadership honoree by Virginia Business. The award recognizes top women executives in Virginia who demonstrate exceptional leadership, civic engagement, mentorship, and a commitment to breaking glass ceilings in th ...

Core Insights - Predictmedix AI Inc. has launched a Clinical-Trial AI Platform aimed at enhancing efficiency in the $70 billion clinical trials market by helping pharmaceutical sponsors and contract research organizations (CROs) model, plan, and adapt clinical trials more effectively [1][4]. Company Overview - Predictmedix AI Inc. is an emerging leader in AI-powered health and safety technology, focusing on rapid health screening and remote patient care solutions globally [9]. - The company utilizes SmartHealth AI Stations, which employ multispectral cameras to analyze physiological data patterns and predict various health issues [9]. Product Features - The Clinical-Trial AI Platform is built on patented technology and high-fidelity datasets, designed to function as a real-time digital support system for trial planning [2]. - Key features include: - Adaptive Simulation Engine for running "what-if" scenarios and updating projections based on new data [6]. - Patient-Site Optimization to improve recruitment and reduce dropouts through AI recommendations [6]. - Cost & ROI Modeling to estimate budget impacts alongside predicted clinical outcomes [6]. - Interactive Dashboards for visualizing risk, cost, and patient flow [6]. - Compliance-Integrated AI to support audit and regulatory processes [6]. Market Context - The global clinical trials market is projected to exceed $70 billion by 2027, creating a demand for tools that can reduce trial failures, improve patient recruitment, and manage costs [4]. - The platform aims to address these industry needs with scalable, real-time analytics [4]. Distinctive Capabilities - The platform features continuous intelligence, end-to-end automation, multi-trial orchestration, and cost-outcome integration for unified decision support [7]. - It draws on over 500,000 SmartHealth scans, achieving approximately 95% accuracy for vital-sign detection [8].